HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 53 filers reported holding HARROW HEALTH INC in Q2 2019. The put-call ratio across all filers is 4.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $82,000 | – | 16,508 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,343,817 | $40,360,000 | 16.67% |
| Invenire Partners, LP | 453,794 | $5,477,293,000 | 8.38% |
| Acuitas Investments, LLC | 337,949 | $4,079,000 | 4.23% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 188,539 | $2,276,000 | 2.47% |
| Ophir Asset Management Pty Ltd | 1,714,464 | $20,694,000 | 1.88% |
| Private Capital Management, LLC | 1,029,356 | $12,424,000 | 1.80% |
| Birchview Capital, LP | 180,000 | $2,173,000 | 1.53% |
| Diametric Capital, LP | 224,090 | $2,705,000 | 1.36% |
| Uniplan Investment Counsel, Inc. | 694,257 | $8,379,000 | 0.64% |
| EAM Investors, LLC | 224,046 | $2,704,000 | 0.59% |